Vadastuximab talirine in combination for newly diagnosed AML
3 Dec 2016
Vadastuximab talirine in combination for newly diagnosed AML
Gold nanoparticles and cancer treatment
Yeast cell cycle; what has this taught us?
Target mutations in lung cancer
New optimism for advanced breast cancer patients failing antiestrogens: Opening audience survey
Biology and function of CDKs
Clinical data on breast cancer trials
CDK 4/6 inhibitors: Management of side effects
What involvement do stem cells have in disease and resistance?
Using adoptive cell therapy to fight cancer
Benefits and problems of allogeneic stem cell transplantation as multiple myeloma treatment
Biomarkers of sensitivity and resistance